INTERNATIONAL PATENT: CSPC MEGALITH BIOPHARMACEUTICAL CO., LTD., 石药集团巨石生物制药有限公司 FILES APPLICATION FOR "CDCP1-TARGETING ANTIBODY-DRUG CONJUGATE AND USE THEREOF"

GENEVA, May 3 -- CSPC MEGALITH BIOPHARMACEUTICAL CO., LTD. (519, Cangsheng Road, High-Tech Development Zone,Shijiazhuang, Hebei 050027), 石药集团巨石生物制药有限公司 (中国河北省石家庄市高新区仓盛路519号) filed a patent application (PCT/CN2025/129449) for "CDCP1-TARGETING ANTIBODY-DRUG CONJUGATE AND USE THEREOF" on Oct 23, 2025. With publication no. WO/2026/086855, the details related to the patent application was published on Apr 30, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by...